WallStreetZenWallStreetZen

How to Buy Biomarin Pharmaceutical Stock

Biomarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions.

Biomarin Pharmaceutical stock last closed at $88.61, up 0.99% from the previous day, and has decreased 3.16% in one year. It has overperformed other stocks in the Biotechnology industry by 0.03 percentage points. Biomarin Pharmaceutical stock is currently +16.56% from its 52-week low of $76.02, and -11.73% from its 52-week high of $100.38.

At the moment, there are 188.68M shares of BMRN outstanding. The market value of BMRN is $16.72B. In the last 24 hours, 1.03M BMRN shares were traded.

How to Buy Biomarin Pharmaceutical Stock

Not sure how to invest in Biomarin Pharmaceutical stock? Here's how.
  1. Choose where to buy Biomarin Pharmaceutical stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you determine where to buy Biomarin Pharmaceutical stock.
  2. Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Put funds into your investment account: Select your payment method and add your details.
  4. Research Biomarin Pharmaceutical stock: The Biomarin Pharmaceutical ticker symbol is BMRN. Is Biomarin Pharmaceutical stock a good investment? Should you buy shares of BMRN? How do BMRN's underlying business fundamentals look? Do top analysts think Biomarin Pharmaceutical is a good buy? Why has BMRN's stock price moved recently? (Hint: Our stock research tools can help you decide if BMRN is a good stock to buy).
  5. Make your BMRN buy order: Decide if you will purchase BMRN shares at the current market price or use a limit order to buy BMRN shares at a given price.
  6. Get notifications regarding your BMRN investment: Create a watchlist to important notifications about your new investment in Biomarin Pharmaceutical shares.

Step 1: Choose where to buy Biomarin Pharmaceutical stock

You need an online brokerage account in order to access the NASDAQ market and buy BMRN stock.

A brokerage account allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

We believe that eToro is the best stock brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to global markets: From Technology to Healthcare, New York to London — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by opening an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've selected your brokerage, you'll need to fill out some personal info so you are able to buy BMRN stock today.

How to Open a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal details to open a new brokerage account.
  1. Send your information by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your investment account

Now that you've created your account on apps for stock market, your next step is to transfer the money for your investment:

Check out the walkthrough below if you need help transferring money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Biomarin Pharmaceutical stock

Once you have decided on the best place to buy Biomarin Pharmaceutical stock, it's absolutely critical to research their stock prior to investing, so you actually understand the risk as well as the upside.

Biomarin Pharmaceutical Metrics

BMRN Price
$88.61
1w %
4.54%
1y %
-3.16%
5y %
0.76%
P/E
99.56x
P/B
3.38x
P/S
6.88x
PEG
1.05x
Revenue
$2.42B
Earnings
$167.65M
Fore. Rev. Growth
12.2%
Fore. Earn. Growth
94.71%
Market Cap
$16.72B
Next Earnings
Apr 24, 2024
Next Dividend
N/A

Biomarin Pharmaceutical Fundamentals

WallStreetZen was built to help part-time investors perform more accurate fundamental analysis quickly.

You can view all of the due diligence checks on BMRN's stock page.

Is BMRN stock undervalued or overvalued?

You can use many financial metrics, analyses, models, and charts to gauge BMRN's intrinsic value.

Using relative valuations ratios:

  • BMRN may be overvalued based on its P/E ratio of 99.56x, relative to Biotechnology industry P/E ratio of 14.3x
  • BMRN could be undervalued based on its P/B ratio of 3.38x, relative to Biotechnology industry P/B ratio of 6.2x
  • BMRN could be overvalued based on its PEG ratio of 1.05x

You can do additional valuation research on BMRN's stock here.

How do BMRN Financials look?

Pros:

  • BMRN has a low debt to equity ratio of 0.38.
  • BMRN profit margin has gone up from 6.8% to 6.9% in the past year.
  • There are more short-term assets than long-term liabilities on the BMRN balance sheet.
  • Total BMRN debt is lower than 5 years ago, relative to shareholder equity.
  • BMRN earnings of $205.90M is not enough to cover its interest payments.
  • There are more short-term assets than short-term liabilities on the BMRN balance sheet.

Cons:

  • BMRN's operating cash flow of $159.26M allows it to safely service it's debt of $1.09B.

Is it a good time to buy Biomarin Pharmaceutical stock, according to analysts?

Out of 10 Equities analysts who give recommendations on BMRN, the consensus analyst rating on BMRN is a Buy

It's important to keep in mind that analyst forecasts are not recommendations, nor are they financial advice.

Latest BMRN Analyst Upgrades/Downgrades

Paul Matteis, a bottom 13% analyst from Stifel Nicolaus reiterates BMRN with a strong buy rating and maintains their BMRN price target from $101.00 to $101.00, on Dec 21, 2023.

Kostas Biliouris, a top 29% analyst from BMO Capital maintains BMRN with a buy rating and lowers their BMRN price target from $102.00 to $100.00, on Nov 3, 2023.

Matthew Harrison, a bottom 44% analyst from Morgan Stanley maintains BMRN with a strong buy rating and lowers their BMRN price target from $125.00 to $117.00, on Nov 2, 2023.

Gena Wang, a top 29% analyst from Barclays maintains BMRN with a strong buy rating and lowers their BMRN price target from $125.00 to $111.00, on Nov 2, 2023.

William Pickering, a top 42% analyst from Bernstein upgrades BMRN to a hold rating and announces their BMRN price target of $82.00, on Oct 23, 2023.

You can dive deeper into what analysts are saying on the Biomarin Pharmaceutical stock forecast page.

BMRN Technicals

SMA10
85.42
SMA20
85.8
SMA50
88.22
SMA100
89.97
SMA200
89.3
MACD
-0.51
MACD Signal
-1.04
MACD Histogram
0.53
RSI
58.19
Stochastic %K
88.05
Stochastic %D
65.72
StochRSI %K
100
StochRSI %D
93.28

Is BMRN Making Money?

Last year, BMRN earnings were $167.65M. Over the past 3 year, BMRN's earnings have gone up by -93.27% per year. This was slower than the Biotechnology industry average of 15.69%.

Last year, BMRN revenue was $2.42B. In the past five year, BMRN's revenue has gone up by 10.16% per year. This was slower than the Biotechnology industry average of 29.77%.

You can analyze BMRN's earnings and revenue performance here.

Latest Insiders Trades at BMRN

In the past 12 months, executives and large shareholders at BMRN have sold more shares than they have bought.

Erin Burkhart, GVP Chief Accounting Officer of BMRN, was the latest BMRN insider to sell. They sold $31,199.64 worth of BMRN stock on Mar 18, 2024.

Dig into more about who owns BMRN shares here.

Can I get consistent income from BMRN stock?

No, Biomarin Pharmaceutical doesn't provide an income stream by paying out dividends.

What do other investors have to say about BMRN?

One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Make your BMRN buy order

There are two primary order types:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are mostly fine for most investors.
  • Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
    If you want to be sure you're buying or selling at a given price, place a limit order.

Click the Open Trade button and your broker will place your order.

If you need additional help with buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get notifications regarding your BMRN investment

Now that you own some BMRN shares, you'll want to keep up with your new investment.

Start a watchlist to track your BMRN stock.

BMRN Feed

How to Buy Stock in Biomarin Pharmaceutical

To summarize, here are the 6 steps to buy Biomarin Pharmaceutical stock:

  1. Choose where to buy Biomarin Pharmaceutical stock
  2. Open your brokerage account
  3. Put funds into your investment account
  4. Research Biomarin Pharmaceutical stock
  5. Make your BMRN buy order
  6. Get notifications regarding your BMRN investment

If you are looking for a online brokerage, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to watch your new investment in Biomarin Pharmaceutical, create a watchlist on WallStreetZen today.

NASDAQ: BMRN
$88.61+0.87 (+0.99%)
Updated Mar 27, 2024
Open eToro Account
NASDAQ: BMRN
$88.61+0.87 (+0.99%)
Updated Mar 27, 2024
Open eToro Account

FAQ

How much does it cost to buy one Biomarin Pharmaceutical share?

As of Mar 27, 2024, it costs $88.61 to buy one share of Biomarin Pharmaceutical stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.113 shares of BMRN.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Biomarin Pharmaceutical stock?

According to 10 Wall Street analysts who monitor Biomarin Pharmaceutical, their consensus recommendation is to buy Biomarin Pharmaceutical stock.

What is the best way to buy Biomarin Pharmaceutical stock?

One way to place an order for Biomarin Pharmaceutical stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.